PDF version
About Acrobat Reader

BACKGROUND:
AIDS and U.S. Hispanics
CDC's Role
Combating Complacency
Drug Use and Sexual
HIV Transmission

The Global Epidemic
HIV Prevention for
African Americans

Linking Science & Prev.
Occupational HIV
Transmission

Perinatal HIV Prevention
Prevention and Treatment
of STDs

Prevention for Minority
and Young Women

TB and HIV
Treatment Advances
Young and Minority Men
at High Risk

Young People at Risk
 
Addressing the Global Epidemic: CDC's International Activities

The Centers for Disease Control and Prevention's (CDC) research program is dedicated to advancing biomedical and behavioral science that promotes HIV/AIDS prevention in the United States and worldwide. Research focuses on understanding the dynamics of HIV transmission and on developing and improving prevention technologies and strategies to control the spread of HIV/AIDS and minimize its consequences.

The World Health Organization and the Joint United Nations Programme on HIV/AIDS (UNAIDS) estimate that, worldwide, as many as 42 million people have been infected with HIV since the pandemic's onset, and each day 16,000 more become infected. Recognizing the urgency of the epidemic, CDC is committed to HIV/AIDS research within, as well as outside of, U.S. borders. To understand AIDS on a global level, research must address issues and conditions unique to different countries and communities within countries. Many developing countries severely affected by the epidemic lack the research capacity, public health infrastructure, and financial and human resources to respond to the epidemic. CDC's international research underscores the importance of developing and implementing diverse interventions to address issues among varied populations and to do so quickly and cost-effectively.


Cooperative Efforts Yield Prevention Benefits

Through collaborative agreements with governments of Côte d'Ivoire (Projet RETRO-CI) and Thailand (HIV/AIDS Collaboration), CDC participates in studies designed to increase our understanding of the epidemiology of HIV-1 and HIV-2 infections and to facilitate prevention and care efforts in the host countries and the United States. Specific research areas include:

Addressing mother-to-child (perinatal) HIV transmission in developing countries around the world, where 1,600 babies are born with HIV each day. Collaborative research by CDC and the Thai Ministry of Public Health found that a short course of AZT given late in pregnancy and during delivery reduced the rate of HIV transmission to infants of infected mothers by half and is safe for use in the developing world. The findings offer real hope to many developing nations that previously had no realistic options to prevent HIV-infected pregnant women from transmitting infection to their babies. CDC continues working with host countries and public health agencies worldwide to implement the short course AZT regimen as widely as possible. Researchers continue to study other factors of mother-to-child HIV transmission, such as the role of breast-feeding in HIV transmission in developing countries where breast-feeding is an important source of nutrition for newborns.

Developing effective interventions for high-risk populations in Côte d'Ivoire and Thailand. Researchers have collaborated with host countries to implement and evaluate HIV prevention interventions among injection drug users, female sex workers and other populations at risk to provide them with the knowledge and support needed to protect themselves from HIV infection. Many of these interventions have proven effective, particularly programs to increase condom use and treat sexually transmitted diseases among female sex workers.

Identifying possible factors that may confer immunity to HIV. Collaborative researchers from CDC and the Thai and Ivorian Ministries of Public Health are working to determine how certain groups of female sex workers have remained uninfected despite numerous exposures to HIV. Initial research looked at possible genetic characteristics that might lead to immunity in certain individuals and is now focusing on the role the immune response to HIV may play in protection from infection. Researchers believe this research could have important implications for the future development of an HIV vaccine.

Working to reduce the impact of HIV/AIDS in developing countries through practical treatment regimens. A joint study by CDC and the Côte d'Ivoire Ministry of Public Health found the first evidence that trimethoprim/sulfamethoxazole (TMP/SMX) (commonly referred to as cotrimoxazole, Bactrim or Septra) can significantly reduce the rate of death among HIV-infected tuberculosis patients in Africa. New data demonstrate a 48% reduction in mortality and a 44% reduction in hospitalizations among HIV-infected tuberculosis patients taking TMP/SMX. These dramatic findings offer a realistic option to help reduce the overwhelming death toll from HIV in the developing world.

Conducting genetic analyses and collecting surveillance data on the genetic variations of HIV strains in host countries. Because of the increasing spread of HIV subtypes across international boundaries, these data may have implications for developing HIV vaccines and for promptly detecting and treating different HIV strains worldwide.

Gathering surveillance data on HIV/AIDS trends among sentinel groups, such as female sex workers, pregnant women, STD patients, injection drug users, and children, to target, develop and evaluate new interventions.

Monitoring the natural progression of HIV infection to shed light on how to improve survival and quality of care for HIV-infected people, thus diminishing the personal and societal costs of the epidemic.

Investigating risk factors, including other diseases (e.g., STDs and tuberculosis), associated with HIV infection to identify links between these illnesses and to develop effective treatment strategies that can be applied globally.

Investigating factors associated with heterosexual transmission of HIV. Worldwide, more people have been infected through heterosexual contact than any other exposure. And in the United States, heterosexual transmission accounts for a growing percentage of both HIV infections and AIDS cases. Understanding the biomedical and behavioral aspects of heterosexual transmission is key to containing HIV in this country and around the world.


CDC Presentations Related to International Topics

Orals:

"Case-Control Study of Cervical Cancer and HIV Infection in Abidjan, Côte d'Ivoire," Georgette Adjorlolo-Johnson

"New HKA-A11 HIV-1 Subtype E Cytotoxic Lymphocyte (CTL) Epitopes Identified in Studies of Thai HIV-Infected Female Sex Workers," Kyle Bond/Janet McNicholl

"Decline in Prevalence of HIV Infection and Sexually Transmitted Diseases and Increase in Condom Use Among Female Sex Workers in Abidjan, Côte d'Ivoire," Mamadou O. Diallo

"Assessment of Eligibility for Antiretroviral Therapy Among HIV-Infected Patients Attending Selected Outpatient Clinics in Abidjan, Côte d'Ivoire," Gaston Djomand

"Study Drug Adherence and Tolerance Within a Randomized Clinical Trial to Evaluate a Short-Course Regimen of Zidovudine to Reduce Mother-to-Child Transmission of HIV-1 in Abidjan, Côte d'Ivoire," Ehounou Ekpini

"HIV and HBV Positive Donors: Implications for Blood Safety and Donor Deferral in Kenya," Guillermo Herrera/Robert Janssen

"Viral Load and CD4 Cell Count in Injecting Drug Users (IDUs) Newly Infected with HIV-1 Subtypes B' and E, Bangkok," Timothy Mastro

"A Critical Assessment of HIV/AIDS Prevention Interventions for People on the Move in Sub-Saharan Africa," Thomas Painter

"HIV Infection and TB Associated with Injecting Drug Use and Resistant M. tuberculosis, Bangkok, Thailand," Juree Punnotok

"Randomized Placebo-Controlled Trial of Short-Course Oral ZDV to Reduce Perinatal HIV Transmission, Thailand," Nathan Shaffer

"HIV-Specific Cytotoxie T Lymphocytes (CTLs) in Thai Exposed Uninfected (EU) Female Sex Workers (FSWs) are Directed to Multiple Regions of HIV-1 Subtype E," Busarawan Sriwanthana

"RNA and DNA PCR for Early Diagnosis of Infants Born to HIV-Infected Mothers, Thailand," Nancy Young

Posters:

"Clinical and Immunologic Spectrum of Disease Among 2261 HIV-1 Infected Patients at a Hospital in Bangkok," Pauli Amornkul

"Human Dignity Promotion and Civil Society Building as Interventions to Prevent STD/AIDS: Examples from Turkey," Sevgi Aral

"(Double Trouble)2: HIV/TB Profiles from the U.S. and the U.K. Derived from Multiple Surveillance Systems," Diane Bennett

"Surveillance Trends of HIV-1 Subtypes B' and E Throughout Thailand, 1992-1997," Thongpoon Chaowanachan

"Clinical Outcome and Survival Associated with Perinatal HIV-1 Subtype E, Bangkok, Thailand," Kulkanya Chokephaibulkit

"Safety, Tolerance and Adherence of Late Oral ZDV to Reduce Perinatal HIV Transmission, Bangkok," Rutt Chuachoowong

"Presence of Anti-HIV Antibodies in Cervicovaginal Fluid of HIV-Seronegative Female Sex Workers in Abidjan, Côte d'Ivoire," Peter D. Ghys

"Clinical Manifestations of Advanced HIV Disease Using Hospital Surveillance, Clinical and Autopsy Data in Abidjan, Côte d'Ivoire," Alan E. Greenberg

"Incarceration as a Continuing HIV Risk Factor Among Injecting Drug Users in Bangkok," Krit Hiranras

"Prevalence of HIV and Syphilis Infections Among Pregnant Women Attending Urban Antenatal Clinics in Côte d'Ivoire," Sidibe Kassim

"Leaving Sex Work: Work History in a Cohort of Female Sex Workers in Northern Thailand," Peter Kilmarx

"Similar Risk Factors for New Infection with HIV-1 Subtypes B' and E Among Injecting Drug Users (IDUs) in Bangkok, Thailand," Dwip Kitayaporn

"Immune Activation Markers and Chemokine Receptor 5 (CCR5) Genotype in Highly Exposed but Persistently Seronegative Female Sex Workers in Abidjan, Côte d'Ivoire," Stephania Koblavi-Deme

"Female Sex Workers in Abidjan, Côte d'Ivoire: Determinants of Entry into Sex Work and Perspectives for Leaving," Yao Konan

"Disease Progression and Mortality Among HIV-Infected Female Sex Workers in Upper Northern Thailand," Khanchit Limpakarnjanarat

"Estimation of Vaccine Efficacy for Prophylactic HIV Vaccines from Field Trials in Developing Countries," Ira M. Longini

"Willingness to Participate in an HIV Vaccine Efficacy Trial Among Injecting Drug Users (IDUs) in Bangkok, Thailand," Kathleen MacQueen

"Trends in Condom Use Between 1991 and 1997 and Obstacles to 100% Condom Use in Female Sex Workers (FSWs) in Abidjan, Côte d'Ivoire," G. Mah-bi

"Field Evaluation of the HIV-1 Amplicor Monitor and NucliSens Quantitative HIV-1 RNA PCR Assay in Persons Infected with HIV-1 Subtype A in Abidjan, Côte d'Ivoire," John Nkengasong

"Distribution of HIV-1 Subtypes Among HIV-1 Positive Tuberculosis (TB) Patients in the Interior of Côte d'Ivoire," John Nkengasong

"HIV-1 Plasma Viral Load and CD4 Counts in Surviving and Non-Surviving HIV-Infected Tuberculosis Patients, Abidjan, Côte d'Ivoire," Thierry H. Roels

"HIV-1 RNA Viral Load and CD4 Counts Before and After Tuberculosis (TB) Therapy in HIV-Infected TB Patients in Abidjan, Côte d'Ivoire," Madeleine Sassan-Morokro

"Cord Blood ZDV Concentration After Intermittent Oral Administration During Labor, Thailand," Wimol Siriwasin

"Utility of Single or Dual Rapid Tests in the Detection of HIV in Pregnant Women, Kenya," Richard Steketee

"HIV and Malaria Overlap and Do Interact in Sub-Saharan African Pregnant Women," Richard Steketee


"Molecular Epidemiology of HIV-1 in Switzerland," Thomas Stoeckli

"Genetic Characterization of Incident HIV-1 Subtype B and E Strains from Injecting Drug Users (IDUs) in Bangkok, Thailand," Shambavi Subbarao

"Perceptions of HIV Transmission Risk Among Regular Partners and Prospects for the Evaluation and Use of Vaginal Microbicides in Northern Thailand," Kanokwan Tharawan


"HIV-1 Incidence, Subtypes, and Follow Up in a Prospective Cohort of Injecting Drug Users (IDUs) in Bangkok, Thailand," Suphak Vanicheseni


"Where Do Female Sex Workers Go for Sexual Health Care? A Study from Abidjan, Côte d'Ivoire," Beatrice Vuylsteke

"HIV-1 Plasma Viral Load in Tuberculosis Patients with Single HIV-1 and Dual HIV-1/HIV-2 Infections, Abidjan, Côte d'Ivoire," Stefan Z. Wiktor

   


                                                           
    Combating Complacency - HIV Prevention, Geneva '98